β-Glucocerebrosidase is maximally active at pH 5.5, the pH of the lysosomal compartment. Within the lysosome it remains associated with the membrane, where it binds and degrades its substrate
glucocerebroside (GluCer). It requires the activating protein
Saposin C as well as negatively charged lipids for maximal catalytic activity. The role of Saposin C is not known; however, it is shown to bind both the lysosomal membrane and the lipid moieties of GluCer, and therefore may recruit GluCer to the active site of the enzyme. β-Glucocerebrosidase is specifically and
irreversibly inhibited by the glucose analog
Conduritol B epoxide. Conduritol B epoxide binds to the GCase active site, where the enzyme cleaves its
epoxide ring, forming a permanent
covalent bond between the enzyme and the inhibitor. Initially, GCase was thought to be one of the few lysosomal enzymes that does not follow the
mannose-6-phosphate pathway for trafficking to the
lysosome. A study in
I-cell disease fibroblasts (in which the
phosphotransferase that puts
Mannose 6-phosphate on proteins to target them to the lysosome is defective) showed targeting of GCase to the lysosome independent of the M6P pathway. The lysosomal transporter and integral membrane protein
LIMP-2 (Lysosomal Integral Membrane Protein 2) was shown to bind GCase and facilitate transport to the lysosome, demonstrating a mechanism for M6P-independent lysosomal trafficking. This conclusion was called into question when a crystal structure of GCase in complex with
LIMP-2 showed a
Mannose 6-phosphate moiety on LIMP-2, suggesting the complex can also follow the traditional
mannose-6-phosphate pathway. == Clinical significance ==